Biomarker Robustness
Biomarker Robustness is the capacity of a biomarker to consistently and reliably maintain its performance across diverse experimental conditions, populations, and analytical settings, thereby ensuring its validity and generalizability in clinical and research applications.
20
Publications
951
Citations
107
Authors
67
Institutions
Publications per year
2017–2026
9
Parents
20
Konstantin G. Arbeev, Svetlana Ukraintseva, Olivia Bagley et al. · The Journals of Gerontology Series A · 2018 · 49 citations · Full text
Education, Biostatistics, Aging +16
1–5 of 20
107
2
h-index
2
h-index
2
h-index
1
h-index
Ventana Research Corporation (United States), United States
1 publications · 13 citations
1
h-index
1–5 of 107
67
Skåne University Hospital
Lund, Sweden
2 h-index
3 publications
317 citations

Lund University
Lund, Sweden
2 h-index
3 publications
317 citations

Sahlgrenska University Hospital
Gothenburg, Sweden
2 h-index
4 publications
462 citations

University of Gothenburg
Gothenburg, Sweden
2 h-index
10 publications
1.3K citations
GlaxoSmithKline (United States)
Philadelphia, United States
2 h-index
14 publications
3.4K citations
UK Dementia Research Institute
London, United Kingdom
2 h-index
2 publications
231 citations
University College London
London, United Kingdom
2 h-index
2 publications
231 citations
Stanford Medicine
Stanford, United States
1 h-index
1 publications
44 citations
1–8 of 67
2 publications · 107 citations
2
h-index
1 publications · 145 citations
1
h-index
1 publications · 31 citations
1
h-index
1 publications · 36 citations
1
h-index
1 publications · 19 citations
1
h-index
1–5